Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase subunit beta prime (β′) is a core component of RNA polymerases found in all domains of life. It is essential for gene expression by synthesizing RNA using ribonucleoside triphosphates. The β′ subunit forms part of the active center responsible for catalyzing ribonucleotide polymerization and binds to template DNA. In bacteria, the core enzyme (α₂ββ'ω) requires sigma factors for promoter recognition. Several antibacterial drugs target β′ to inhibit bacterial RNAP activity.
Inhibition of bacterial RNAP activity by binding regions involving β′, blocking formation of open complexes required for transcription start.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase subunit beta prime (β′).